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Wastewater treatment plants play an important role in the emergence of antibiotic resistance. They 
provide a hot spot for exchange of resistance within and between species. Here, we analyse and 
quantify the genomic diversity of the indicator Escherichia coli in a German wastewater treatment 
plant and we relate it to isolates’ antibiotic resistance. Our results show a surprisingly large pan-
genome, which mirrors how rich an environment a treatment plant is. We link the genomic analysis 
to a phenotypic resistance screen and pinpoint genomic hot spots, which correlate with a resistance 
phenotype. Besides well-known resistance genes, this forward genomics approach generates many 
novel genes, which correlated with resistance and which are partly completely unknown. A surprising 
overall finding of our analyses is that we do not see any difference in resistance and pan genome size 
between isolates taken from the inflow of the treatment plant and from the outflow. This means that 
while treatment plants reduce the amount of bacteria released into the environment, they do not 
reduce the potential for antibiotic resistance of these bacteria.
In 1945, Alexander Fleming, the discoverer of Penicillin, warned of antibiotic resistance. Today, the WHO echoes 
this warning, calling antibiotic resistance a global threat to human health. Humans are at the center of the mod-
ern rise of resistance. The human gut1, clinical samples2,3, soil4,5, and wastewater6 all harbor resistant bacteria and 
resistance genes. At the heart of modern resistance development is a human-centered network of clinics, industry, 
private homes, farming, and wastewater. Recent studies suggest that wastewater contains a significant amount 
of antibiotic resistant E. coli, specifically extended-spectrum beta-lactamase-producing E. coli7. Particularly, 
multidrug-resistant (MDR) clones (normally defined as those resistant to three or more drug classes8) are of great 
concern. Past studies have documented the presence of MDR E. coli isolates in wastewater on the basis of phe-
notypic resistance testing9, but a comprehensive analysis of the clonal composition of MDR E. coli in wastewater 
employing whole genome analysis is largely lacking. Therefore, the current information on the genomic diversity 
of antibiotic resistant E. coli in wastewater is very limited. Recent metagenomic studies have documented that 
human-associated bacteria are strongly reduced in the wastewater and its treatment process10. To investigate the 
genomic diversity as well as virulence genes and resistance determinants for wastewater E. coli, we proceeded as 
sketched in Fig. 1. We collected 1178 E. coli isolates from a waste treatment plant’s inflow and outflow in the city 
of Dresden, Germany. We selected 20 antibiotics, which are the most prescribed ones in the area from which 
the wastewater inflow originates (data provided by the public health insurer AOK). We analyzed the isolates’ 
resistance to these 20 antibiotics and selected 103 isolates for whole genome sequencing. Our analysis reveals 
a surprisingly high genomic diversity of MDR E. coli in the wastewater with very flexible genomes harboring a 
high variation of virulence genes and resistance determinants. Using this diversity, we developed a computational 
approach to identify not only known, but also novel genes correlating with resistance.
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Results
The wastewater pan-genome. The concept of evolution implies that genomes of organisms of the same 
species differ. Differences range from single nucleotide polymorphisms to large genome rearrangements. As 
a consequence, E. coli possesses a core of genes present in all genomes, as well as genes only present in some 
genomes, or even just in one. The union of all of these genes is called the pan-genome. It is believed, that the E. coli 
core genome comprises around 1400–1500 genes, while the pan-genome may be of infinite size11.
To assess the degree of genomic flexibility of the wastewater isolates, we relate the wastewater pan-genome 
and the wastewater core genome. At 16582 genes, the wastewater pan-genome is nearly six times larger than the 
wastewater core genome of 2783 genes, a reservoir of some 14000 genes. Despite this large reservoir, the size 
difference of nearly 1000 genes between the wastewater E. coli core genome and the whole species core genome 
suggests that the full diversity of E. coli is still not covered in our wastewater sample.
The balance between maintaining the core genome and spending energy on acquisition of new genetic mate-
rial can be captured by the ratio of the core genome size and the average genome size, which is 4700 genes in 
our sample. This means that only 1400/4700 = 30% of genes in our wastewater E. coli are core genes. Most of 
the non-core genes are very unique and appear only in one or two isolates each. More precisely, 50% of the 
pan-genome genes appear in only one or two isolates each. This implies that the investigated wastewater E. coli 
are highly individual.
This high diversity is also illustrated in Fig. 2, which compares the wastewater E. coli to a clinical dataset of 
E. coli. The figure clearly shows that the E. coli of clinical origin are more homogeneous and hence their 
pan-genome is smaller. In contrast, the diversity of the wastewater E. coli match other datasets comprising mix-
tures of commensal and pathogenic E. coli, as well as Shigella genomes (see Table 1). This underlines the great 
Figure 1. Wastewater plays an important role in antibiotic resistance development. Wastewater Escherichia 
coli isolates were tested for antibiotic resistance and sequenced. Many isolates are multi-drug resistant and have 
markers often found in pathogenic isolates. Their large pan-genome is a source of potentially novel resistance 
genes.
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diversity of E. coli genomes in the wastewater. Interestingly, the variation of the wastewater genomes after the 
treatment plant was not reduced.
Resistance genes in the wastewater pan-genome. Wastewater E. coli are known to host antibiotic 
resistance genes. While there are many known resistance genes (see e.g. CARD12), they fall mostly into a few 
groups, such as beta-lactamases. Here, we seek to confirm and expand the space for resistance genes. Firstly, we 
measured antibiotic resistance in all 1178 isolates to the 20 antibiotics. As mentioned above, these 20 antibiotics 
include the most widely used antibiotics in the wastewater plant’s region. They included kanamycin and cephalo-
tin, which are under debate regarding their intrinsic resistance, but to which E. coli are shown to be susceptible in 
many studies13–18. Figure 3 shows that 4 isolates are susceptible to kanamycin and 45 to cephalotin.
Figure 3 reveals a high degree of resistance and big differences between different antibiotics, including a gen-
eral trend indicating greater resistance to antibiotics that have been available for longer. Specifically, isolates were 
significantly more resistant to antibiotics from the 50 s and 60 s namely, chloramphenicol, cephalotin, doxycy-
cline, fosfomycin, gentamicin, kanamycin, nalidixic acid, tetracycline & tobramycin, than the more recent antibi-
otics (Welch test, p-value < 0.0025, also significant without including kanamycin and cephalotin). However, there 
is no significant difference in the number of resistances between isolates from the inflow and the outflow (p-value 
0.0001), suggesting that wastewater treatment is not affecting resistance.
Next, we tried to predict the resistance observed in Fig. 3 using known resistance genes. To this end, we 
employed ResFinder19 and could predict resistances across all classes of drugs (see Supp Fig. 4) at an accuracy of 
46%. While these are promising results, they show also that the known resistance genes used in the analysis are 
not sufficient for a perfect prediction. Therefore, we wanted to expand the link from genotype to phenotype by 
going beyond known resistance genes. Thus, we correlated the presence of each gene in the sequenced isolates 
with their phenotypic antibiotic resistance profiles.
Meropenem and imipenem are clinically important antibiotics, which are very effective, as can be seen in 
Fig. 3. Hardly any of the isolates are resistant to them. Since both drugs work so well, correlation of presence and 
Figure 2. The pan-genome at the outflow has the same size as at the inflow, suggesting that highly flexible 
Escherichia coli emerge from a treatment plant. The wastewater pan-genome is larger than a clinical pan-
genome and of similar size to (see Table 1) highly diverse samples comprising pathogenic, commensal, and lab 
Escherichia coli, as well as Shigella.
Ref Pan Core Strains Path. Comm. Lab Shig.
This study 16582 2783 92 28 62 0 0
Kaas et al.54 16373 1702 186 171 15
Vieira et al.55 14986 1957 29 21 8 0 6
Gordienko et al.56 12000 2000 32 16 6 3 7
Lukjancenko et al.57 13000 1472 53 35 11 7 0
Rasko et al.58 13000 2344 17 14 1 2 0
Touchon et al.28 11432 1976 20 10 3 0 7
Table 1. Highly diverse samples comprising pathogenic, commensal, and lab Escherichia coli, as well as Shigella. 
Path. = Pathological. Comm. = Commensal. Lab. = Laboratory. Shig. = Shigella.
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absence of genes to resistance/susceptibility will be naturally poor. Hence, we have excluded both compounds 
from the correlation analysis. For each of the 18 remaining antibiotics, we list the top ten correlating genes in 
the table shown in Fig. 4. These 180 genes comprise 88 unique confirmed genes, including many well-known 
resistance genes, such as efflux pumps (MT1297 and emrE), membrane and transport proteins (aida-I, yiaV, yijK, 
pitA, icsA, and pagN), tetracycline (tetA, tetR, and tetC), chloramphenicol (cat), and piperacillin (the beta lacta-
mase bla2) resistance genes. Based on available literature, genes that are known to mediate resistance against the 
respective antibiotic (e.g. tetA mediates resistance against tetracycline and cat mediates resistance against chlo-
ramphenicol) were highlighted in yellow. However, the 180 genes also comprise a large number of open reading 
frames encoding hypothetical proteins (41) and genes not yet linked to antibiotic resistance (116). These genes 
have to be studied further to determine whether they are novel resistance genes or just correlating. (e.g. because 
they are on the same genetic element with a resistance gene). As a consequence, the tet gene, which is a known 
resistance gene against tetracyclins is highlighted in the table shown in Fig. 4, but occurrences of tet, which appear 
among the quinolones are not highlighted in yellow. Nearly all of the identified genes are found both in inflow and 
outflow genomes suggesting that the wastewater treatment does not impact on the presence or absence of known 
resistance genes and genes correlating with resistance.
Virulence genes. Generally, E. coli strains exhibit great variation. Many exist as harmless commensals in the 
human gut, but some are classified as intra- (InPEC) or extra-intestinal pathogenic E. coli (ExPEC20). Based on 
their virulence genes profile the pathogenic potential of E. coli isolates can be determined7. The sequenced isolates 
contain some 700 of nearly 850 E. coli protein sequences representing 400 virulence factors and their isoforms in 
the virulence factor database21, averaging to 153 and to 155 virulence factors per isolate for inflow and outflow, 
respectively. Hence, there is no significant difference (Welch test, CI 95%) between inflow and outflow. In particu-
lar, we found combinations of virulence factors for 16 isolates (see methods), which are indicative of ExPEC. Eight 
of these 16 isolates were obtained from the outflow of the treatment plant (see Fig. 5).
Besides the presence of known virulence factors, pathogenic isolates are more likely to be member of certain 
multi-locus sequence types22 and phylogroups23,24. Broadly, E. coli has seven phylogroups, A, B1, B2, D D, E, F25. 
Commensal as well as intestinal pathogenic E. coli fall mostly into groups A and B126 and ExPEC into B2 and 
D23. Figure 5 shows a phylogenetic tree of the sequenced wastewater E. coli isolates along with the commen-
sal phylogroups A (red) and B1 (blue) and the pathogenicity-associated groups B2 (yellow) and D (green), as 
well as the finer-grained multi-locus sequence types. The tree is based on genomic variations compared to the 
reference genome of E. coli K12 MG1655. Figure 5 reveals that nearly one third of isolates belong to group B2 
Figure 3. 1178 Wastewater Escherichia coli isolates were tested for antibiotic resistance to 20 antibiotics 
covering 4 main classes as well as the Miscellenous class (chloramphenicol and fosfomycin). Nearly all isolates 
are multi-drug resistant. Isolates were highly susceptible to carbapenems (meropenem and imipenem) 
which are beta-lactams. Isolates were also more susceptible to fluoroquinolones than to tetracyclins and 
aminoglycosides. The outflow isolates (n = 322) show similar resistance as inflow (n = 856) (p-value 0.0001), 
suggesting that wastewater treatment is not reducing resistance development.
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and D, in which ExPEC are usually found. In particular, B2 and D include 14 of the 16 potential ExPEC isolates. 
Remarkably, half of the B2 and D isolates are from the wastewater treatment plant’s outflow. To provide a scale for 
phylogenetic relationships of isolates in the tree, consider isolates 1, 2 and 3; isolate 1 is very close to isolate 2, but 
very far from 3. Isolates 1 and 2 have 25,218 single nucleotide polymorphisms (SNPs) in common, while 1 and 3 
share only 4,928 SNPs. Overall, the number of shared SNPs ranges from 647 to 25218 averaging at 5271 SNPs (at 
a standard deviation of 3514).
Discussion
Pan and core genome. It is well known that wastewater treatment reduces the bacterial abundance, in 
addition a recent metagenomic study has shown that the bacterial community in wastewater is very different to 
the human gut community and that the number of detected genera is reduced in the wastewater10. Consequently, 
our expectation was that the genomic diversity of E. coli should be reduced. We were very surprised to find an 
unexpectedly high genomic diversity, which is illustrated in the large pangenome. A possible explanation for this 
high genomic diversity is that the E. coli cells within the wastewater originate not only from human faeces, but 
also from a multitude of different animal faeces collected via the surface runoff into the sewers. This would also 
explain why the pangenome of the wastewater E. coli is considerably larger than the clinical pangenome reported 
by Land et al.27. Generally, many authors have pointed out that E. coli has a large and flexible pan genome. 
Lapierre et al. argue that E. coli appears to have unlimited ability to absorb genetic material and hence its pan 
genome is open11. In a recent study comprising over 2000 genomes Land et al. put this into numbers and arrive at 
a pan genome of 60000–89000 gene families for over 2000 sequenced E. coli genomes27. The study by Land et al. 
(24) is based on clinical isolates, in contrast our study is the first, which has calculated the pangenome of E. coli 
for wastewater. Interestingly, our results seem to be in concordance and suggest that within our study we still have 
not reached the saturation of the detected diversity (Fig. 2), indicating that the full genomic diversity of E. coli 
in the wastewater is probably even larger than what we report here. Worryingly, this is also reflected in a high 
diversity of resistance and virulence genes. This documents that the wastewater contains a significant amount of 
multi-drug resistant (MDR) E. coli, which also carry a suit of virulence genes suggesting that some of those MDR 
have a pathogenic potential. Furthermore, we did not find a significant difference in genomic diversity between 
inflow and outflow of the wastewater treatment plant, suggesting that selection against genome diversity and 
resistance determinants does not seem to occur.
Pathogenic potential and resistance. Resistant bacteria may or may not be pathogenic. While ultimate 
proof for pathogenicity can only be obtained from in vivo studies, we wanted to analyse the genomes for markers 
Figure 4. Top 10 correlating genes for 18 antibiotics from correlation of genomes to resistance phenotype. 
Antibiotics were color-coded based on antibiotic class following the scheme in Fig. 3. The highlighted yellow 
boxes represent genes involved in resistance to the respective antibiotics based on available literature.
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likely to be found in pathogenic bacteria. Here we chose to consider three independent approaches: classification 
by phylogenetic groups, by multi-locus sequence tags, and by identification of specific virulence factors (see 
methods). While the three approaches showed consistent results, they are by no means proof for pathogenicity, 
since there can be exceptions to these classification rules. As an example, consider the strain ED1a (O81), which 
was isolated from a healthy man, but belongs to the phylogenetic group B228. Similarly, pathogenicity may not 
only arise from the acquisition of genes, but also from the loss29.
Regarding resistance there are similar confounding factors. Bacteria may be inherently resistant since generally 
antibiotic resistance is ancient30 and naturally occurring in the environment. Nonetheless, there are pronounced 
differences between pristine and human environments24. This is also supported by Fig. 3, which shows that anti-
biotics introduced in the 50 s and 60 s have more resistances than those introduced later (p-value < 0.0025), 
which suggests, that the naturally occurring resistances do not play a major role in the emergence of observed 
resistances.
From clinic to river. We have shown that there are E. coli at the wastewater outflow, which are multi-drug 
resistant and have markers found in pathogenic bacteria. But are they abundant enough to have an impact in 
the aquatic system they are released into? They do. The percentage of possibly pathogenic E. coli in the outflow 
is considerable and may correspond to a large absolute amount. Caucci et al. quantified the amounts of eight 
antibiotic resistance genes at the inflow and outflow of a wastewater treatment plant31. They found in the order 
of 104 to 108 copies at the inflow and a reduction of three orders of magnitude at the outflow. They argue that the 
reduction relates directly to the bacterial removal rate of the treatment plant and their numbers show that despite 
removal, substantial amounts of resistance genes remain. Also, the number of E. coli are assessed at the wastewater 
treatment plant regularly and they are between 104 and 105 Colony Forming Units (CFU)/ml for the inflow and 
102 and 103 (CFU/ml) for the outflow respectively and the numbers are comparable to other studies32. Generally, 
if an average of 100 E. coli colony forming units (CFU) are released per ml, then 1013 CFUs per day are released 
(assuming a release of 105 m3 per day). This is in accordance with Manaia et al., who showed that 1010–1014 CFU 
of ciprofloxacin-resistant bacteria are released by a mid-sized wastewater treatment plant33. Supporting these 
results, a study in a Japanese river shows the presence of pathogenic E. coli34. In this study they sequenced over 
500 samples from the Yamato river and most of their prevalent multi-drug resistant and clinical strains are also 
present in our samples. In a related study, Czekalski et al. found that particle-associated wastewater bacteria are 
Figure 5. Phylogeny of wastewater Escherichia coli from the inflow (n = 50) and the outflow (n = 42) of a 
wastewater treatment plant. Phylogenetic tree, multi-locus sequence types (shown as numbers in black), and 
phylogroups of 92 sequenced wastewater Escherichia coli isolates reveal 16 potential ExPEC isolates (marked 
with a black star) in phylogroups B2 (yellow) and D (green), which are associated with pathogenicity. Half of 
these 16 isolates stem from the outflow of the treatment plant.
www.nature.com/scientificreports/
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the responsible source for antibiotic resistance genes in the sediments of lake Geneva in Switzerland35. Assuming 
that the river Elbe is comparable to these aquatic systems, it suggests, that the urban environment (including 
clinics) and river are connected with wastewater treatment plants in between.
Composition of phylogroups. It is interesting to compare the breakdown into phylogenetic groups of 
wastewater E. coli to compare samples from human and animal environments. It is, e.g., known that the phyloge-
netic group B2 is more abundant among commensal E. coli from human faeces (43%) than from farm animals 
(11%)36. Therefore, the composition of wastewater E. coli as shown in Fig. 5 resembles commensal E. coli from 
farm animals more closely. Similarly, Tenaillon et al. find that groups A and B1 make up one third in human 
faeces36, whereas we find two thirds. This suggests that animal feces play an important role for resistance also of 
urban wastewater treatment plants. Besides the diverse environments such as soils and activated sludge, animal 
feces are probably part of the explanation for the high observed genomic diversity.
Random sampling and novel resistance mechanisms. The initial 1178 isolates were sampled ran-
domly over different times of the year, from two different inflows and the outflow of the wastewater treatment 
plant. In contrast, the 103 sequenced isolates were chosen in such way that all of the phenotypes encountered 
were represented (see methods). Within a phenotype group isolates were chosen randomly. This random, but 
representative choice and the subsequent link from genotype to phenotype is an example of high-throughput 
hypothesis-free analysis. And although, there was no pre-defined resistance mechanism, which we aimed to 
hit, many of the well-known resistance genes were ranked high. This supports the hope that high-throughput, 
hypothesis-free methods such as deep sequencing will help to uncover novel resistance mechanisms and in par-
ticular that some of the top correlating genes will prove to have a causal link to resistance. The results show 
that the here outlined computational approach to correlate genomic and phenotypic information for wastewater 
E. coli significantly assists to identify a larger part of the existing resistome of E. coli. However, a limitation to the 
method is that it can pinpoint correlating genes if resistances have manifested themselves, but not when they are 
yet to emerge. For future investigations, it will be interesting to expand the analysis to mutations within genes (e.g. 
there are well-known mutations in gyrA and parC conferring quinolone resistance) and in non-coding regions 
(mutations in the promoter region of ampC conferring beta-lactam resistance).
Conclusion
Overall, we have shown for the first time that E. coli isolates from wastewater have a surprisingly large 
pan-genome, which harbors virulence genes, known resistance genes and genes correlating with resistance. We 
developed a computational approach based on genomic and phenotypic correlation for E. coli and show that 
applying this to wastewater will discover novel parts of the resistome in E. coli. Finally, together with the estimates 
on absolute E. coli abundance, we could demonstrate that there is a considerable pathogenic potential in the 
outflow of a wastewater treatment plant. Using E. coli as an example, this study demonstrates the importance of 
investigating wastewater with modern bioinformatics and strain specific genomic analysis in order to estimate 
the extent of genomic variation and resistance determinants for bacteria with clinical relevance present in the 
environment.
Methods
Collection. 1178 samples were collected from the municipal wastewater treatment plant Dresden, Germany. 
Samples were collected on 11/4/2012 (Spring 2012), 30/7/2012 (Summer 2012), 21/1/2013 (Winter 2012), 
27/3/2013 (Spring 2013), 6/8/2013 (Summer 2013), 14/10/2013 (Autumn 2013), and 17/12/2013 (Winter 2013). 
Samples were collected either at the outflow (n = 322, OUT) or at one of two inflow locations (n = 856, Altstadt 
ALT and Neutstadt NEU), representing the area south and north of the river Elbe.
Isolation. E. coli and total coliforms bacteria were enumerated via serial fold dilution plating of the original 
wastewater (triplicate samples). Wastewaters were diluted in double distilled water, until the enumeration of bac-
terial colonies was possible. E. coli and coliform counts were always performed in triplicates. The E. coli colonies 
were selected and picked after overnight growth at 37 °C on a selective chromogenic media (OXOID Brilliance 
Escherichia coli/Coliform Selective Agar, Basingstoke, England). All single colonies recognised as chromogeni-
cally positive E.coli were picked. To reduce the dilution effect on E. coli diversity, extra effort was placed for colony 
picking at the lowest fold dilution. To minimize the risk of colony contamination, picked colonies were spiked 
a second time on the same selective media and pure single colonies were grown overnight on LB media at 37 °C 
and stored on glycerol stock at −80 °C. For the cell counting we used mFC Agar and incubated the plates at 44 °C 
for 20 h ( ± 2 h).
Resistance phenotyping. Antibiotic resistance phenotypes were determined by the agar diffusion method 
using 20 antibiotic discs (OXOID, England) according to EUCAST (or CLSI when EUCAST was not available)7,9. 
The selected drugs belong to the most commonly prescribed antibiotics for diseases caused by bacteria according 
to the German health insurance AOK Plus: piperacillin (100 µg), nalidixic acid (30 µg), chloramphenicol (30 µg), 
imipenem (10 µg), cefotaxime (30 µg), cephalotin (30 µg), kanamycin (30 µg), tetracycline (30 µg), gentamicin 
(10 µg), amikacin (30 µg), ciprofloxacin (5 µg), fosfomycin (50 µg), doxycycline (30 µg), cefepime (30 µg), ceftazi-
dime (10 µg), levofloxacin (5 µg), meropenem (10 µg), norfloxacin (10 µg), cefuroxime sod. (30 µg), tobramycin 
(10 µg)31. After 24 hours of incubation at 37 °C, the resistance diameters were measured. Clustering of antibiotics 
and of isolates was performed using the R function heatmap.2 from the R library37 Heatplus and hierarchical 
clustering of matrices based on Euclidean distances between isolates and between antibiotics.
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Sequencing. To select isolates representative of phenotype, we clustered isolates according to the diameters 
of inhibition zone against the 20 antibiotics using k-means clustering based on Euclidean distances between 
isolates (vectors of 20 inhibition zone diameters). The analysis and graphs were produced using R version 3.2.437. 
As clusters may be highly skewed in number of cluster members, we tested all cluster numbers from 1 to 100 
and plotted within class sum of squares against k. At k = 47, the sum of squares tails off and there is a steep local 
decrease, so that k = 47 was fixed as k-means parameter. We obtained 103 isolates, which were subsequently used 
for sequencing and further analysis. To further validate the choice, we plotted the average number of resistances 
against number of isolates and antibiotics vs. number of isolates for the total 1178 and the selected 103 isolates 
(see Supp Fig. 1) and concluded that both distributions are roughly similar. 3000 ng DNA were extracted from 
each of the 103 selected isolates using MasterPure extraction kit (Epicentre) according to the manufacturer’s 
instructions. Sequencing was performed on an Illumina MiSeq system using V3 chemistry and the Nextera XT 
kit for library preparation.
Assembly. Genomes were assembled with Abyss (version 1.5.2)38. In order to optimize k for the best assem-
bly, k-mer values had to be empirically selected from the range of 20–48 (see Supp Fig. 2) on a per sample basis to 
maximize contiguity3. To determine the k-mer length that achieved highest contiguity, the 28 assemblies per draft 
genome/isolate were compared based on N50 values. 11 assemblies with an N50 statistic of less than 5 × 104 bp 
were excluded39.
Genes. Reference gene clusters were computed from 58 complete E. coli genomes (see Table 2) available in 
June 2015 from NCBI. Genes were identified in wastewater and reference genomes using Prokka (version 1.11)40. 
Genes were clustered at 80% using CD-HIT41 (version 4.6.3, arguments -n 4 -c 0.8 -G 1 -aL 0.8 –aS 0.8 -B 1). 
Genes with over 90% sequence identity, but only 30% coverage, as well as genes with 80% or greater identity and 
covered to phage and virus sequences42 were discarded. A gene cluster is defined to be present in an isolate if there 
is a Prokka gene in the genome, which is longer than 100 amino acids and has over 80% sequence identity and 
coverage against the gene cluster representative.
Pan- and core-genome. To generate the pan- and core-genome size graph we followed the procedure in3,28. 
We had 92 genomes available. We varied i from one to 92. At each subset size i, we randomly selected i genomes 
and computed the sizes of the union (pan) and intersection (core) of gene clusters. This random selection was 
carried out 2000 times in each step.
Gene clusters to rank genes by correlation to phenotype. Prokka genes were identified in all isolate 
genomes and then clustered with CD-HIT at 60% sequence identity and 50% coverage (arguments -n 4 -c 0.6 
-G 1 -aL 0.8 -aS 0.5 -B 1). A 80% identity cutoff was also tried but dismissed, because the 60% threshold yielded 
25% less clusters while adequately clustering homologous gene sequences with lower sequence similarity. This 
threshold value is also supported by the widespread default use of the BLOSUM62 matrix, the basis of which is 
sequences clustered by 62% sequence identity.
Tree. The phylogenetic tree of 92 isolates was built following the procedure of43,44 using FastTree version 2.145. 
Sequence reads were aligned to E. coli K12 MG 1665 and single nucleotide variant calling was carried out using 
GATK46. Quality control for variant calling was performed; variants supported by more than ten reads or like-
lihood score greater than 200 were always in the range of 84–99% of variants called per isolate with the excep-
tion of 2 isolates where only 59% and 60% of the variants were above the threshold for quality and supporting 
reads. FastTree 2.145 was then used to build the maximum likelihood tree based on core single nucleotide poly-
morphisms derived from variant calling. Phylogrouping. For phylogrouping, the in-silico classification method 
established by Salipante et al.3 based on the classical classification by Clermont et al.23 was employed. BLAST was 
performed to check each genome assembly for presence or absence of the genetic elements chuA and yjaA and the 
DNA fragment TspE4.C2 with an identity cutoff ≥90%.
MLST. Concerning epidemiology and Multi-Locus Sequence Typing, we used the webserver at https://cge.cbs.
dtu.dk/services/MLST/ that follows the MLST scheme in47 for predicting MLSTs from whole genome sequence 
data48. 92 Draft genome assemblies were submitted and results were obtained; 2 isolates were unidentified 
demonstrating novel sequence types and have been assigned sequence types ST-8059 and ST-8060 by EnteroBase 
(https://enterobase.warwick.ac.uk/).
Virulence factors. Virulence factors protein sequences were downloaded from VFDB: Virulence Factors 
database21,49. 2180 sequences, which are E. coli related, were chosen. Sequences were then clustered at 80% 
sequence identity using CD-HIT (version 4.6.3, arguments -n 4 -c 0.8 -G 1 -aL 0.8 -aS 0.8 –B 1) to 844 clusters. 
A virulence factor was considered present in an isolate’s genome if there is a Prokka gene in the genome that has 
over 80% sequence identity and coverage against the virulence factor cluster representative.
ExPEC classification. There are intra- and extra-intestinal pathogenic Escherichia coli, which can be classi-
fied from the presence of virulence factors50–53. InPEC are characterised by the virulence factors stx1, stx2, escV, 
and bfpB. They are ExPEC if they contain over 20 of 58 virulence factors afa/draBC, bmaE, gafD, iha cds, mat, 
papEF, papGII, III, sfa/foc, etsB, etsC, sitD ep, sitD ch, cvaC MPIII, colV MPIX, eitA, eitC, iss, neuC, kpsMTII, 
ompA, ompT, traT, hlyF, GimB, malX, puvA, yqi, stx1, stx2, escV, bfp, feob, aatA, csgA, fimC, focG, nfaE, papAH, 
papC, sfaS, tsh, chuA, fyuA, ireA, iroN, irp2, iucD, iutA, sitA, astA, cnf1, sat, vat, hlyA, hlyC, ibeA, tia, and pic.
www.nature.com/scientificreports/
9SCIENTIFIC REPORTS |  (2018) 8:8928  | DOI:10.1038/s41598-018-27292-6
Bioproject Biosample Accession strain
PRJNA380388 SAMN06641941 NBBP00000000 Escherichia coli Win2013_WWKa_OUT_3
PRJNA380388 SAMN06641940 NBBQ00000000 Escherichia coli Win2013_WWKa_OUT_29
PRJNA380388 SAMN06641933 NBBR00000000 Escherichia coli Win2013_WWKa_OUT_18
PRJNA380388 SAMN06641932 NBBS00000000 Escherichia coli Win2013_WWKa_OUT_24
PRJNA380388 SAMN06641931 NBBT00000000 Escherichia coli Win2013_WWKa_OUT_1
PRJNA380388 SAMN06641928 NBBU00000000 Escherichia coli Win2013_WWKa_NEU_65
PRJNA380388 SAMN06641927 NBBV00000000 Escherichia coli Win2013_WWKa_NEU_20
PRJNA380388 SAMN06641926 NBBW00000000 Escherichia coli Win2013_WWKa_NEU_60
PRJNA380388 SAMN06641901 NBBX00000000 Escherichia coli Win2013_WWKa_ALT_23
PRJNA380388 SAMN06641884 NBBY00000000 Escherichia coli Win2012_WWKa_OUT_49
PRJNA380388 SAMN06641883 NBBZ00000000 Escherichia coli Win2012_WWKa_OUT_8
PRJNA380388 SAMN06641882 NBCA00000000 Escherichia coli Win2012_WWKa_OUT_34
PRJNA380388 SAMN06641881 NBCB00000000 Escherichia coli Win2012_WWKa_OUT_35
PRJNA380388 SAMN06641880 NBCC00000000 Escherichia coli Win2012_WWKa_OUT_29
PRJNA380388 SAMN06641879 NBCD00000000 Escherichia coli Win2012_WWKa_OUT_26
PRJNA380388 SAMN06641878 NBCE00000000 Escherichia coli Win2012_WWKa_OUT_33
PRJNA380388 SAMN06641877 NBCF00000000 Escherichia coli Win2012_WWKa_OUT_21
PRJNA380388 SAMN06641876 NBCG00000000 Escherichia coli Win2012_WWKa_OUT_2
PRJNA380388 SAMN06641875 NBCH00000000 Escherichia coli Win2012_WWKa_NEU_7
PRJNA380388 SAMN06641874 NBCI00000000 Escherichia coli Win2012_WWKa_OUT_14
PRJNA380388 SAMN06641873 NBCJ00000000 Escherichia coli Win2012_WWKa_NEU_51
PRJNA380388 SAMN06641872 NBCK00000000 Escherichia coli Win2012_WWKa_NEU_31
PRJNA380388 SAMN06641871 NBCQ00000000 Escherichia coli Win2012_WWKa_NEU_37
PRJNA380388 SAMN06641870 NBCR00000000 Escherichia coli Win2012_WWKa_NEU_16
PRJNA380388 SAMN06641869 NBCS00000000 Escherichia coli Win2012_WWKa_NEU_19
PRJNA380388 SAMN06641868 NBCT00000000 Escherichia coli Win2012_WWKa_NEU_12
PRJNA380388 SAMN06641867 NBCU00000000 Escherichia coli Win2012_WWKa_ALT_65
PRJNA380388 SAMN06641866 NBCV00000000 Escherichia coli Win2012_WWKa_NEU_1
PRJNA380388 SAMN06641865 NBCW00000000 Escherichia coli Win2012_WWKa_ALT_49
PRJNA380388 SAMN06641864 NBCX00000000 Escherichia coli Win2012_WWKa_ALT_54
PRJNA380388 SAMN06641863 NBCY00000000 Escherichia coli Sum2013_WWKa_OUT_5
PRJNA380388 SAMN06641862 NBCZ00000000 Escherichia coli Sum2013_WWKa_OUT_39
PRJNA380388 SAMN06641861 NBDA00000000 Escherichia coli Sum2013_WWKa_OUT_49
PRJNA380388 SAMN06641860 NBDB00000000 Escherichia coli Sum2013_WWKa_OUT_3
PRJNA380388 SAMN06641859 NBDC00000000 Escherichia coli Sum2013_WWKa_OUT_31
PRJNA380388 SAMN06641858 NBDD00000000 Escherichia coli Sum2013_WWKa_OUT_2
PRJNA380388 SAMN06641857 NBDE00000000 Escherichia coli Sum2013_WWKa_OUT_21
PRJNA380388 SAMN06641856 NBDF00000000 Escherichia coli Sum2013_WWKa_NEU_53
PRJNA380388 SAMN06641855 NBDG00000000 Escherichia coli Sum2013_WWKa_NEU_46
PRJNA380388 SAMN06641854 NBDH00000000 Escherichia coli Sum2013_WWKa_NEU_39
PRJNA380388 SAMN06641853 NBDI00000000 Escherichia coli Sum2013_WWKa_ALT_44
PRJNA380388 SAMN06641852 NBDJ00000000 Escherichia coli Sum2013_WWKa_NEU_29
PRJNA380388 SAMN06641851 NBDK00000000 Escherichia coli Spr2013_WWKa_OUT_27
PRJNA380388 SAMN06641844 NBDL00000000 Escherichia coli Sum2013_WWKa_ALT_41
PRJNA380388 SAMN06641843 NBDM00000000 Escherichia coli Sum2013_WWKa_ALT_27
PRJNA380388 SAMN06641842 NBDN00000000 Escherichia coli Spr2013_WWKa_OUT_56
PRJNA380388 SAMN06641841 NBDO00000000 Escherichia coli Sum2013_WWKa_ALT_20
PRJNA380388 SAMN06641840 NBJM00000000 Escherichia coli Spr2013_WWKa_OUT_5
PRJNA380388 SAMN06641839 NBJN00000000 Escherichia coli Spr2013_WWKa_OUT_55
PRJNA380388 SAMN06641838 NBJO00000000 Escherichia coli Spr2013_WWKa_OUT_32
PRJNA380388 SAMN06641837 NBJP00000000 Escherichia coli Spr2013_WWKa_OUT_45
PRJNA380388 SAMN06641822 NBJQ00000000 Escherichia coli Spr2013_WWKa_OUT_15
PRJNA380388 SAMN06641821 NBJR00000000 Escherichia coli Spr2013_WWKa_OUT_29
PRJNA380388 SAMN06641820 NBJS00000000 Escherichia coli Spr2013_WWKa_NEU_6
PRJNA380388 SAMN06641819 NBJT00000000 Escherichia coli Spr2013_WWKa_OUT_11
Continued
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Data availability. Genome assemblies of the analyzed isolates that support the findings of the study will be 
made available on the NCBI upon paper publication (see Table 2).
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